Challenges and opportunities in the network medicine of complex diseases
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 HL155096)
- National Institutes of Health (R01 HL155107)
- National Institutes of Health (R01HL166137)
- National Institutes of Health (U01 HG007691)
- European Commission (CN00000013 CN1)
- Instituto Nazionale di Fisica Nucleare
- American Heart Association (HorizonHealth 2021 101057619)
- American Heart Association (AHA957729)
- American Heart Association (AHA24MERIT1185447)
This publication has 110 references indexed in Scilit:
- Spatiotemporal omics for biology and medicineCell, 2024
- A Network-Based Framework to Discover Treatment-Response–Predicting Biomarkers for Complex DiseasesThe Journal of Molecular Diagnostics, 2024
- Machine learning–based integration of network features and chemical structure of compounds for SARS‐CoV‐2 drug effect analysisCPT: Pharmacometrics & Systems Pharmacology, 2023
- Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationiScience, 2022
- Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Cell, 2020
- Molecular networks in Network Medicine: Development and applicationsWIREs Mechanisms of Disease, 2020
- Network Medicine in PathobiologyThe American Journal of Pathology, 2019
- Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric CancerCell Reports, 2019
- Interactome Networks and Human DiseaseCell, 2011
- Michaelis–Menten dynamics in complex heterogeneous networksPhysica A: Statistical Mechanics and its Applications, 2005